ask="8.960"
ask_size="100"
average_daily_volume="19"
bid="N/A"
bid_size="N/A"
book_value="0.000"
change="+0.000"
change_from_200_day_moving_average="-6.930"
change_from_50_day_moving_average="-3.961"
change_from_52_week_high="-10.395"
change_From_52_week_low="0.545"
change_in_percent="+0.000%"
close="7.295"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="N/A"
ebitda="0.00"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="0.000"
eps_estimate_next_year="N/A"
ex_dividend_date="N/A"
float_shares="N/A"
high="N/A"
high_52_weeks="17.690"
last_trade_date="2/1/2017"
last_trade_price="7.295"
last_trade_size="N/A"
last_trade_time="3:38pm"
low="N/A"
low_52_weeks="6.750"
market_capitalization="8.39B"
moving_average_200_day="14.225"
moving_average_50_day="11.256"
name="TrovaGene
Inc."
notes="N/A"
one_year_target_price="N/A"
open="6.210"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-48.718%"
percent_change_from_50_day_moving_average="-35.192%"
percent_change_from_52_week_high="-58.762%"
percent_change_from_52_week_low="+8.074%"
previous_close="7.295"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="1150000000"
short_ratio="0.000"
stock_exchange="NCM"
symbol="TROVU"
volume="70"
weeks_range_52="6.750 - 17.690"
